Global private equity and venture capital news and research

Posts Tagged ‘Advanced Technology Ventures’

29 January 2014

PowerVision secures $20m in Series D funds

Implantable lens developer PowerVision has raised $20m in Series D capital from existing investors.

29 October 2013

Calithera raises $35m Series D from Adage Capital, existing backers

cancer band pink_sq Venture capital firm Adage Capital Partners has led a $35m Series D round for biotech company Calithera Biosciences, which develops novel cancer therapeutics.

18 July 2013

VC-backed fuel developer Coskata withdraws IPO

Venture capital-backed alternative fuel company Coskata, has withdrawn from plans to carry out an initial public offering that it had hoped would garner it $100m.

3 July 2013

New enterprise software fund for key ATV partners could spell end for firm

Bob Hower and Bill Wiberg, a pair of key partners at US early-stage investor Advanced Technology Ventures are reportedly in talks with investors to raise a $75m fund focusing on enterprise software, leading to rumours the firm could be coming to an end.

8 May 2013

Venture-backed biopharma Portola eyes $127m Nasdaq IPO

Venture-backed biopharmaceutical company Portola Pharmaceuticals is targeting $127m from its listing on Nasdaq.

10 April 2013

Foundation Capital raises $282m for seventh fund

Menlo Park-based green investor Foundation Capital has closed its seventh venture capital fund on $282m.

3 April 2013

Morgenthaler, ATV life sciences spinout Lightstone eyes up to $250m for debut fundp

rock-boulder-stone Lightstone Ventures has revealed it could raise up to $250m for its debut fund after being created by spinout investment teams from two other venture firms last year.

20 February 2013

Women’s healthcare company Gynesonics raises $21m from VC investors

A group of venture capital firms has stumped up $21m in a Series D financing round for US-based women’s healthcare company Gynesonics.

12 February 2013

Holaira raises $10m from existing venture investors

A group of venture capital funds have provided $10m in series C financing to medical devices maker Holaira.

26 October 2012

GlaxoSmithKline VC arm leads $35m Thrasos Therapeutics round

Thrasos Therapeutics kidney - AltAssets Private Equity News The corporate venture arm of pharmaceutical giant GlaxoSmithKline has led a $35m financing round for kidney injury treatment company Thrasos Therapeutics.

Page 1 of 212

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014